Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	209.46	24.94	8.06
Graham Fair Price	-1.22	52.07	52.71
PEG	290.18	-3.04	0.78
Price/Book	13.07	2.44	2.16
Price/Cash Flow	32.89	62.69	47.18
Prices/Earnings	20.42	14.06	11.68
Price/Sales	-5.29	7.41	7.82
Price/FCF	32.89	62.69	47.18
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-13.91	0.84	0.98
Operating Margin	-72.93	0.18	0.68
ROA	-5.71	< 0.005	< 0.005
ROE	0.05	0.04	-6.11
ROIC	0.11	0.03	-69.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.54	< 0.005	168253.63
Dividends QOQ	0.09	< 0.005	-89.94
EBIT QOQ	0.03	-0.67	2583.92
EPS QOQ	0.15	-0.05	-69.14
FCF QOQ	0.29	-0.13	-53.39
Revenue QOQ	-0.01	0.22	1562.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	22203.75	0.00	inf
Days Sales Outstanding (DSO)	119.94	148.74	24.01
Inventory Turnover	< 0.005	0.00	inf
Debt/Capitalization	0.25	0.28	11.08
Quick Ratio	4.03	4.14	2.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	51.73	52.73	1.94
Cash	92.92	110.39	18.80
Capex	-0.24	-0.24	1.86
Free Cash Flow	2.36	2.05	-13.26
Revenue	14.25	17.35	21.70
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.76	3.12	-17.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.52	-12.98	-268.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating